FIB-4 is a simple score that estimates your risk of advanced liver fibrosis using four routine values: age, AST, ALT and platelet count. It sorts people into low, indeterminate, or high risk. It's a screening filter, not a diagnosis — a low score is reassuring, while indeterminate or high scores mean the next test (usually elastography), not a conclusion.
Section accent: --clay (MASLD pillar).
What FIB-4 is (and isn't)
FIB-4 (Fibrosis-4 Index) is a noninvasive risk estimate for advanced liver fibrosis. Its appeal is that it uses values most people already have from routine bloodwork — no extra test, no cost. In current AASLD and international pathways, it's the recommended first step to decide who needs further liver-fibrosis assessment.
What it is not: it is not a measurement of liver fat, not a diagnosis of fibrosis, and not a substitute for elastography or biopsy. It is a filter that tells you which bucket you're in and what to do next. → The W8Experts Diagnostic Approach
What it measures and how it's calculated
FIB-4 combines four routine inputs:
FIB-4 = (Age × AST) ÷ (Platelet count × √ALT)
- Age — fibrosis risk rises with age (this is also its main weakness; see below).
- AST and ALT — liver enzymes; rising AST relative to ALT can accompany more advanced disease.
- Platelet count — tends to fall as fibrosis/portal hypertension advances.
You don't calculate it by hand — the lab or an online calculator does — but knowing the ingredients explains its blind spots. Notably, ALT and AST are in the formula, yet significant fibrosis can occur with normal enzymes, which is exactly why FIB-4 (which weights other factors too) can flag risk that enzymes alone would miss. → "My Liver Tests Are Normal…"
The cutoffs — what your number means
For assessing advanced fibrosis risk in MASLD (standard adult interpretation):
| FIB-4 | Category | What it means | Typical next step |
|---|---|---|---|
| < 1.3 | Low risk | Advanced fibrosis unlikely; strong negative predictive value | Reassure; manage metabolic risk; recheck periodically (e.g., every ~1–3 yrs by risk) |
| 1.3 – 2.67 | Indeterminate | Can't be classified on FIB-4 alone | Second-line test — elastography (FibroScan/VCTE) or ELF |
| > 2.67 | High risk | Higher likelihood of advanced fibrosis | Elastography and/or referral to hepatology for further evaluation |
Two things to hold onto: 1. FIB-4's greatest strength is its low-end rule-out: a score under 1.3 is genuinely reassuring for advanced fibrosis in most adults. 2. A high score is a flag, not a diagnosis. It raises the pre-test probability enough to justify the next test — it does not by itself mean you have advanced fibrosis. False positives are common, especially with age.
The age problem (read this if you're over 65)
FIB-4 puts age in the numerator, so scores drift upward with age regardless of true liver fibrosis. In older adults the standard 1.3 lower cutoff produces too many false positives.
- Age ≥ 65: a higher lower cutoff of ~2.0 is generally used to reduce false positives (so 1.3–2.0 in a 70-year-old is often not treated as "indeterminate" the way it would be at 45).
- Under ~35: FIB-4 performs less well at the young end too, and results should be interpreted cautiously.
This age dependence is the single most important caveat when reading your own score. It's a good example of why a number needs a clinician's context, not just a calculator. → FibroScan & Elastography for the more age-robust next test.
Other things that distort FIB-4
- Anything that changes platelets or AST/ALT independently of liver fibrosis — other liver disease, alcohol, hemolysis, certain medications, acute illness — can move the score.
- A single value is a snapshot. Trends over time and the full clinical picture matter more than one reading.
- It was validated in specific populations; performance varies, and it is a probability tool, not a verdict.
Where FIB-4 sits in the pathway
FIB-4 is step 3 of the W8Experts noninvasive pathway — after identifying steatosis and assessing metabolic risk, and before elastography:
METABOLIC RISK
↓
STEATOSIS ASSESSMENT (ultrasound/imaging)
↓
FIB-4 ← you are here (initial fibrosis-risk stratification)
↓
ELASTOGRAPHY (FibroScan/VCTE or MRE) — when FIB-4 is indeterminate or high
↓
LOWER / INTERMEDIATE / HIGHER RISK
↓
MONITOR · INTERVENE · REFER / FURTHER EVALUATE
Not everyone needs every step. FIB-4's job is to make sure the people who do need elastography or referral get there — and to spare the low-risk majority unnecessary testing. → The W8Experts Diagnostic Approach
SIGNATURE — "What the evidence says: FIB-4"
- What we know: FIB-4 is a validated, cheap first-line filter with an excellent low-risk rule-out; guidelines build fibrosis pathways around it.
- What we think: Used correctly (with age-adjusted cutoffs and a defined next step), it safely reduces unnecessary referrals and biopsies.
- What we don't know / its limits: It misclassifies a meaningful minority — especially older adults (false positives) and some with early disease (false negatives) — so it is never the final word.
- What patients should do: Treat a low score as reassuring, an indeterminate/high score as a reason for the next test (elastography), and interpret any result with a clinician, not a calculator alone.
Questions patients ask
What is a good FIB-4 score?
Under 1.3 is low-risk and reassuring for advanced fibrosis in most adults. Over 65, a cutoff around 2.0 is used instead. Grade A 🟢
My FIB-4 is high — does that mean I have liver scarring?
Not necessarily. A high score raises the probability enough to justify the next test (elastography), but it isn't a diagnosis and false positives are common, especially with age. Grade A 🟢
Can FIB-4 be normal if I still have liver disease?
Yes — false negatives happen, particularly in earlier disease, which is why the whole clinical picture and follow-up matter. Grade B 🟡
Why is my FIB-4 higher just because I'm older?
Age is part of the formula, so scores rise with age independent of true fibrosis. That's why a higher cutoff (~2.0) is used over 65. Grade A 🟢
Is FIB-4 the same as a FibroScan?
No. FIB-4 is a blood-based estimate; FibroScan physically measures liver stiffness. FIB-4 comes first; FibroScan is the more definitive next step. Grade A 🟢 → FibroScan & Elastography
Do normal liver enzymes mean my FIB-4 will be fine?
Not reliably — normal ALT/AST don't exclude fibrosis, and FIB-4 weights age and platelets too. Grade A 🟢 → Normal Enzymes
KEEP READING
- FibroScan & Elastography — the next test after an indeterminate or high FIB-4.
- The W8Experts Diagnostic Approach — the full fat-vs-risk pathway.
- "My Liver Tests Are Normal…" — why enzymes don't rule out disease.
- Liver Biopsy: When It's Needed — the reference standard, used selectively.
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: [date] · References: AASLD Practice Guidance on MASLD (2023); Sterling FIB-4 derivation; guideline-based FIB-4 cutoffs (<1.3 / >2.67; age-adjusted ~2.0 at ≥65). Educational only; not a diagnosis.
